RIA
NVCR icon

Regal Investment Advisors’s NovoCure NVCR Stock Holding History

Regal Investment Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,160
Closed -$201K – 295
2020
Q4 		$201K Buy
+1,160
New +$159K 0.02% 451

Other funds holding NVCR

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Regal Investment Advisors's NVCR Position: Q1 2021 in Review

Regal Investment Advisors sold out of NovoCure (NVCR) in Q1 2021, closing a stake of 1,160 shares — an estimated $201K sold.

Regal Investment Advisors first reported a position in NVCR in Q4 2020 and held it in 1 quarter. The position peaked at $201K in Q4 2020. 327 funds tracked by Wall St. Rank hold NVCR as of Q1 2021.

  • Regal Investment Advisors reported no remaining NovoCure position as of Q1 2021 after selling out during the quarter.
  • Regal Investment Advisors sold 1,160 NovoCure shares in Q1 2021, an estimated $201K.
  • Regal Investment Advisors first reported a position in NovoCure in Q4 2020 and held it in 1 quarter.
  • Regal Investment Advisors's NovoCure position peaked at $201K in Q4 2020.
  • 327 funds tracked by Wall St. Rank held NovoCure as of Q1 2021.

Based on Regal Investment Advisors's 13F filing for Q1 2021, filed 12 May 2021.